4.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:千円) |
| 前連結会計年度 (2024年3月31日) | 当連結会計年度 (2025年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 7,465,192 | 7,039,571 |
売掛金及び契約資産 | 3,463,780 | 2,774,194 |
前払費用 | 255,432 | 243,949 |
立替金 | 1,265,542 | 841,301 |
その他 | 320,723 | 763,363 |
貸倒引当金 | △21,895 | △35,183 |
流動資産合計 | 12,748,776 | 11,627,196 |
固定資産 | | |
有形固定資産 | | |
建物附属設備 | 97,663 | 97,132 |
減価償却累計額 | △57,570 | △64,433 |
建物附属設備(純額) | 40,093 | 32,698 |
工具、器具及び備品 | 359,402 | 329,599 |
減価償却累計額 | △280,516 | △274,827 |
工具、器具及び備品(純額) | 78,885 | 54,771 |
リース資産 | 694,798 | 530,162 |
減価償却累計額 | △295,007 | △222,236 |
リース資産(純額) | 399,791 | 307,926 |
有形固定資産合計 | 518,770 | 395,396 |
無形固定資産 | | |
のれん | 3,547,866 | 3,144,985 |
その他 | 117,467 | 94,944 |
無形固定資産合計 | 3,665,333 | 3,239,929 |
投資その他の資産 | | |
投資有価証券 | 272,198 | 272,500 |
長期前払費用 | 1,382 | 23,215 |
差入保証金 | 384,805 | 387,839 |
繰延税金資産 | 948,648 | 829,225 |
投資その他の資産合計 | 1,607,034 | 1,512,779 |
固定資産合計 | 5,791,138 | 5,148,106 |
資産合計 | 18,539,915 | 16,775,302 |
| | (単位:千円) |
| 前連結会計年度 (2024年3月31日) | 当連結会計年度 (2025年3月31日) |
負債の部 | | |
流動負債 | | |
短期借入金 | 600,000 | 600,000 |
1年内返済予定の長期借入金 | 493,640 | 400,008 |
未払金 | 847,585 | 625,898 |
未払費用 | 349,336 | 296,258 |
未払法人税等 | 264,241 | 27,781 |
未払消費税等 | 22,481 | 3,105 |
前受金 | 2,521,964 | 2,420,387 |
預り金 | 2,271,085 | 2,755,857 |
賞与引当金 | 199,310 | 197,669 |
その他 | 199,240 | 150,247 |
流動負債合計 | 7,768,885 | 7,477,214 |
固定負債 | | |
長期借入金 | 1,499,950 | 1,099,942 |
リース債務 | 304,677 | 228,044 |
退職給付に係る負債 | 704,710 | 693,219 |
その他 | 26,671 | 23,425 |
固定負債合計 | 2,536,008 | 2,044,630 |
負債合計 | 10,304,894 | 9,521,845 |
純資産の部 | | |
株主資本 | | |
資本金 | 214,043 | 214,043 |
利益剰余金 | 7,315,200 | 6,437,301 |
自己株式 | △657,461 | △657,464 |
株主資本合計 | 6,871,781 | 5,993,881 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 25,631 | 24,449 |
為替換算調整勘定 | 1,287,406 | 1,193,809 |
退職給付に係る調整累計額 | 50,201 | 41,317 |
その他の包括利益累計額合計 | 1,363,239 | 1,259,576 |
純資産合計 | 8,235,021 | 7,253,457 |
負債純資産合計 | 18,539,915 | 16,775,302 |
E2170621830株式会社リニカルLinical Co., Ltd.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2024-04-012025-03-31FY2025-03-312023-04-012024-03-312024-03-311falsefalsefalse218302023-03-31jppfs_cor:TreasuryStockMember218302023-03-31jppfs_cor:ShareholdersEquityMember218302023-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember218302023-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember218302023-04-012024-03-31jppfs_cor:RetainedEarningsMember218302023-04-012024-03-31jppfs_cor:TreasuryStockMember218302023-04-012024-03-31jppfs_cor:ShareholdersEquityMember218302023-04-012024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember218302025-03-31jppfs_cor:ShareholdersEquityMember218302025-03-31jppfs_cor:CapitalStockMember218302025-03-31jppfs_cor:RetainedEarningsMember218302025-03-31jppfs_cor:TreasuryStockMember218302025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember218302025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember218302024-04-012025-03-31jppfs_cor:ShareholdersEquityMember218302024-04-012025-03-31jppfs_cor:CapitalStockMember218302024-04-012025-03-31jppfs_cor:RetainedEarningsMember218302024-04-012025-03-31jppfs_cor:TreasuryStockMember218302024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember218302024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember218302023-03-31jppfs_cor:RetainedEarningsMember218302023-03-31jppfs_cor:CapitalStockMember218302024-04-012025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember218302025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember218302023-04-012024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember218302023-04-012024-03-31jppfs_cor:CapitalStockMember218302024-03-31jppfs_cor:CapitalStockMember218302024-03-31jppfs_cor:RetainedEarningsMember218302024-03-31jppfs_cor:TreasuryStockMember218302024-03-31jppfs_cor:ShareholdersEquityMember218302024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember218302024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember218302023-04-012024-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember218302024-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember218302023-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember218302024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember218302025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember218302023-04-012024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember218302024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember218302023-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember218302025-03-31218302024-04-012025-03-31218302024-03-31218302023-04-012024-03-31218302025-05-15218302023-03-31218302023-04-012024-03-31tse-acedjpfr-21830:CMAReportableSegmentsMember218302023-04-012024-03-31jpcrp_cor:ReconcilingItemsMember218302025-03-31jpcrp_cor:ReportableSegmentsMember218302025-03-31tse-acedjpfr-21830:CROReportableSegmentsMember218302025-03-31tse-acedjpfr-21830:CMAReportableSegmentsMember218302025-03-31jpcrp_cor:ReconcilingItemsMember218302024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember218302024-04-012025-03-31tse-acedjpfr-21830:CROReportableSegmentsMember218302024-04-012025-03-31tse-acedjpfr-21830:CMAReportableSegmentsMember218302024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember218302024-03-31jpcrp_cor:ReportableSegmentsMember218302024-03-31tse-acedjpfr-21830:CROReportableSegmentsMember218302024-03-31tse-acedjpfr-21830:CMAReportableSegmentsMember218302024-03-31jpcrp_cor:ReconcilingItemsMember218302023-04-012024-03-31jpcrp_cor:ReportableSegmentsMember218302023-04-012024-03-31tse-acedjpfr-21830:CROReportableSegmentsMemberxbrli:pureiso4217:JPY